Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.

Saved in:
Bibliographic Details
Title: Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
Authors: Gregg LP; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas., Richardson PA; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas., Nambi V; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Research and Cardiovascular Research Institute, Baylor College of Medicine, Michael E. DeBakey Veterans Affairs Hospital, Houston, Texas., Petersen LA; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas., Matheny ME; Geriatrics Research Education and Clinical Care Service, Tennessee Valley Healthcare System VA, Nashville, Tennessee.; Departments of Biomedical Informatics, Biostatistics, and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Virani SS; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Section of Cardiology, Department of Medicine, Aga Khan University, Karachi, Pakistan., Navaneethan SD; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
Source: Journal of the American Society of Nephrology : JASN [J Am Soc Nephrol] 2025 Jan 01; Vol. 36 (1), pp. 87-98. Date of Electronic Publication: 2024 Aug 26.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health, on behalf of the American Society of Nephrology Country of Publication: United States NLM ID: 9013836 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-3450 (Electronic) Linking ISSN: 10466673 NLM ISO Abbreviation: J Am Soc Nephrol Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39186372
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gregg+LP%22">Gregg LP</searchLink>; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Richardson+PA%22">Richardson PA</searchLink>; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Nambi+V%22">Nambi V</searchLink>; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Department of Cardiovascular Research and Cardiovascular Research Institute, Baylor College of Medicine, Michael E. DeBakey Veterans Affairs Hospital, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Petersen+LA%22">Petersen LA</searchLink>; Michael E. DeBakey VA Medical Center Health Services Research and Development, Center for Innovations in Quality, Effectiveness and Safety, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.<br /><searchLink fieldCode="AU" term="%22Matheny+ME%22">Matheny ME</searchLink>; Geriatrics Research Education and Clinical Care Service, Tennessee Valley Healthcare System VA, Nashville, Tennessee.; Departments of Biomedical Informatics, Biostatistics, and Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.<br /><searchLink fieldCode="AU" term="%22Virani+SS%22">Virani SS</searchLink>; Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas.; Section of Cardiology, Department of Medicine, Aga Khan University, Karachi, Pakistan.<br /><searchLink fieldCode="AU" term="%22Navaneethan+SD%22">Navaneethan SD</searchLink>; Selzman Institute for Kidney Health, Section of Nephrology, Baylor College of Medicine, Houston, Texas.; Section of Health Services Research, Baylor College of Medicine, Houston, Texas.; Renal Section, Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas.; Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229013836%22">Journal of the American Society of Nephrology : JASN</searchLink> [J Am Soc Nephrol] 2025 Jan 01; Vol. 36 (1), pp. 87-98. <i>Date of Electronic Publication: </i>2024 Aug 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+on+behalf+of+the+American+Society+of+Nephrology%22">Wolters Kluwer Health, on behalf of the American Society of Nephrology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9013836 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-3450 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210466673%22">10466673 </searchLink><i>NLM ISO Abbreviation: </i>J Am Soc Nephrol <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39186372
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1681/ASN.0000000000000477
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 87
    Titles:
      – TitleFull: Sodium-Glucose Cotransporter-2 Inhibitor and Glucagon-Like Peptide-1 Receptor Agonist Discontinuation in Patients with CKD.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gregg LP
      – PersonEntity:
          Name:
            NameFull: Richardson PA
      – PersonEntity:
          Name:
            NameFull: Nambi V
      – PersonEntity:
          Name:
            NameFull: Petersen LA
      – PersonEntity:
          Name:
            NameFull: Matheny ME
      – PersonEntity:
          Name:
            NameFull: Virani SS
      – PersonEntity:
          Name:
            NameFull: Navaneethan SD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2025 Jan 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1533-3450
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Journal of the American Society of Nephrology : JASN
              Type: main
ResultId 1